Bot pharma: US pharmaceutical company Eli Lilly made a $2.75B deal with Hong Kong-based Insilico Medicine to bring drugs developed by generative AI to market.
When our AI overlords decide we're too much of a hindrance, they'll use designer toxins in our pharma supply chains to get rid of the carbon units infesting the hive mind.
| Sysop: | Eric Oulashin |
|---|---|
| Location: | Beaverton, Oregon, USA |
| Users: | 122 |
| Nodes: | 16 (0 / 16) |
| Uptime: | 06:17:38 |
| Calls: | 9,714 |
| Calls today: | 4 |
| Files: | 9,588 |
| D/L today: |
390 files (427M bytes) |
| Messages: | 435,271 |
| Posted today: | 6 |